Safety and Feasibility of TWIICE Rise - Phase 2
Key facts
- Who runs it
- TWIICE
- Where
- Nottwil, SwitzerlandSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 15 people, planned
- Started
- 25 Jul 2023
- Expected to end
- 31 Jul 2027
- Type of study
- Interventional
- Treatments tested
- TWIICE Rise
- Record updated
- 10 March 2026
Who can take part
- Age
- 18 years to 70 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 30 criteriaShow less
Who can take part
- Informed Consent signed by the subject
- Traumatic and non-traumatic SCI
- Motor incomplete SCI with Neurological Level of Injury (NLI) C5-L5, or Motor Complete SCI with NLI T1-L5 as determined by the ISNCSCI
- Male and non-pregnant, non-lactating female aged 18 to 70 years old
- At least 6 months after injury
- Able to stand or maintain upright position with a standing device (e.g., 'Easy stand') for at least ten minutes without clinical symptoms of orthostatic hypotension
- Able to use crutches
- Able to sit with knees and hips >= 90° flexion
- Phase 1: Height of 160 to 180 cm, Phase 2: Height of 160 to 190 cm
- Phase 1: Weight of <80 kg, Phase 2: Weight of <100 kg
Who cannot take part
- Severe concurrent medical disease, illness, or condition
- Individuals with a pacemaker, defibrillator, drug delivery pump, or other electrical devices if malfunctions could lead to serious adverse events
- History of severe neurological injuries other than spinal cord injury (e.g., Multiple Sclerosis, Cerebral Palsy, Amyotrophic Lateral Sclerosis, Traumatic Brain Injury, Stroke)
- Systemic or peripheral infection influencing wearing an exoskeleton
- Diagnosis of coronary artery disease that precludes moderate to intense exercise
- A medical diagnosis in the patient chart of atherosclerosis, congestive heart failure, or history of myocardial infarction
- Untreated sever hypertension (systolic blood pressure >180 mmHg, diastolic blood pressure >120 mmHg)
- History of lower extremities or pelvic fragility fractures within the last two years
- Current pressure ulcer of the arms, trunk, pelvic area, or lower extremities
- Psychiatric or cognitive conditions that may interfere with the trial
- Other severe illness that the study physician considers in his/her clinical judgment to be exclusionary
- Ability to walk 10 meters without physical assistance of a person
- Deep vein thromboses in lower extremities of less than 6 months duration
- Unstable spine or unhealed limbs
- Heterotopic ossification that impairs joint mobility
- Significant contractures defined as flexion contracture limited to 20 the hip and knee
- Severe spasticity (Modified Ashworth grade 4) or uncontrolled clonus
- Diagnosis of severe osteoporosis/penia: Dual Energy X-ray Absorptiometry (DXA) results indicating a t-score below -3.5 at the femoral neck or the total proximal femur bone, and knee bone mineral density (BMD) < 0.60 gm/cm2
- Pregnancy or women who plan to become pregnant during the study period, and lactating women
- Patient is currently involved in any other interventional study
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 70 years old?
Where in Switzerland
- Swiss Paraplegic Centre NottwilNottwil, SwitzerlandContact: Mario Widmer, PhDTaking people
About the trial
What the trial wants to find out
The aim of this study is to assess the safety and the feasibility of two versions of TWIICE Rise for exoskeleton-assisted ambulation in patients with a spinal cord injury.
Read full original descriptionShow less
This study is done in two phases:
The first phase evaluates the safety and feasibility of TWIICE Rise 0.0 with 5 patients over 6 sessions in clinic. The second phase is being conducted with TWIICE Rise 1.0. This version has potentially improved functionalities based on feedback from Phase 1. Safety and feasibility will be assessed with 10 patients over 10 sessions in different settings (clinic, home, and community environment).
The group in the trial
- Exoskeleton assisted ambulationTreatment being tested
Phase 1: Five participants will undergo a training programme with the TWIICE Rise 0.0 two times a week for up to 6 weeks for a total of 6 sessions. Phase 2: Ten participants will undergo a training programme with the TWIICE Rise 1.0 2-3 times a week for up to 10 weeks for a total of 10 sessions.
Treatment: TWIICE Rise
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Two-phase Pilot Study on the Safety and Feasibility of TWIICE Rise for Exoskeleton-assisted Ambulation in Patients With Spinal Cord Injury
- Fit questions
- Built from NCT07461259, who can take part
- Record updated
- 10 March 2026